Insider Transactions in Q2 2022 at Jaguar Health, Inc. (JAGX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2022
|
John Micek |
BUY
Exercise of conversion of derivative security
|
Direct |
12,133
+50.0%
|
-
|
|
May 18
2022
|
Jonathan B. Siegel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,133
+50.0%
|
-
|
|
May 18
2022
|
Gregory J Divis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,133
+50.0%
|
-
|
|
May 18
2022
|
James J Bochnowski |
BUY
Exercise of conversion of derivative security
|
Direct |
13,133
+15.11%
|
-
|
|
Apr 05
2022
|
Lisa A Conte CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+45.92%
|
-
|
|
Apr 05
2022
|
Steven R. King |
BUY
Exercise of conversion of derivative security
|
Direct |
13,333
+50.0%
|
-
|
|
Apr 05
2022
|
Jonathan S. Wolin |
BUY
Exercise of conversion of derivative security
|
Direct |
6,666
+50.0%
|
-
|
|
Apr 05
2022
|
Carol R. Lizak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,513
+26.56%
|
-
|
|
Apr 05
2022
|
Pravin R Chaturvedi Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
-
|